Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Neuberg

Showing results (231-240 of 354) with videos related to

Pageof 36
Sort By:
JCI Insight|July 22, 2025
SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathwayBo Zhang, Prajish Iyer, Meiling Jin, et al.
Blood|June 9, 2018
Mass cytometry of Hodgkin lymphoma reveals a CD4<sup>+</sup> regulatory T-cell-rich and exhausted T-effector microenvironmentFathima Zumla Cader, Ron C J Schackmann, Xihao Hu, et al.
Blood|September 17, 2014
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patientsRafael Bejar, Allegra Lord, Kristen Stevenson, et al.
Blood|February 4, 2010
Inactivation of LEF1 in T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Takaomi Sanda, Wenxue Ma, et al.
Blood|August 2, 2011
Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997Mitchell R Smith, Donna Neuberg, Ian W Flinn, et al.
The Journal of Molecular Diagnostics : JMD|December 4, 2014
Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimensChristopher D Carey, Daniel Gusenleitner, Bjoern Chapuy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2012
Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemiaJennifer R Brown, Megan Hanna, Bethany Tesar, et al.
Cancer Cell|September 15, 2012
Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphomaStefano Monti, Bjoern Chapuy, Kunihiko Takeyama, et al.
Blood|June 4, 2014
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemiaMohini Rajasagi, Sachet A Shukla, Edward F Fritsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2014
Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantationRafael Bejar, Kristen E Stevenson, Bennett Caughey, et al.
Pageof 36

Showing results (231-240 of 354) with videos related to

Sort By:
Pageof 36
JCI Insight|July 22, 2025
SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathwayBo Zhang, Prajish Iyer, Meiling Jin, et al.
Blood|June 9, 2018
Mass cytometry of Hodgkin lymphoma reveals a CD4<sup>+</sup> regulatory T-cell-rich and exhausted T-effector microenvironmentFathima Zumla Cader, Ron C J Schackmann, Xihao Hu, et al.
Blood|September 17, 2014
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patientsRafael Bejar, Allegra Lord, Kristen Stevenson, et al.
Blood|February 4, 2010
Inactivation of LEF1 in T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Takaomi Sanda, Wenxue Ma, et al.
Blood|August 2, 2011
Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997Mitchell R Smith, Donna Neuberg, Ian W Flinn, et al.
The Journal of Molecular Diagnostics : JMD|December 4, 2014
Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimensChristopher D Carey, Daniel Gusenleitner, Bjoern Chapuy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2012
Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemiaJennifer R Brown, Megan Hanna, Bethany Tesar, et al.
Cancer Cell|September 15, 2012
Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphomaStefano Monti, Bjoern Chapuy, Kunihiko Takeyama, et al.
Blood|June 4, 2014
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemiaMohini Rajasagi, Sachet A Shukla, Edward F Fritsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2014
Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantationRafael Bejar, Kristen E Stevenson, Bennett Caughey, et al.
Pageof 36